Skip to the content

Director, Business Analysis & Insight Jazz Pharmaceuticals

Dennis Engelke

Since joining Jazz Pharmaceuticals in 2015, Dennis has been working in the International Portfolio Planning team responsible for the analysis and monitoring of the current Haematology/Oncology and Sleep Medicine business by providing commercial insights which meaningfully improve brand strategies across the International region. In addition, he is assessing development assets or acquisition targets, contributing towards the final Go/No-Go decision. He is working in close collaboration with the commercial, medical, and business development leadership teams ensuring identification of insights, transfer of best practice and a holistic assessment of new product targets.

Dennis has 12 years of hands-on experience in the innovative and generic pharmaceutical industry and held previously global strategic marketing, business development and business intelligence positions for Specialty Pharmaceuticals at Actelion Pharmaceuticals and Fresenius Kabi.

He holds a Masters degree in Business and Economics from the Universities of Hamburg (Germany) and Uppsala (Sweden).

EphMRA 2020 - Antwerp - June 23-25 - put the dates in your diary!

The 2019 Conference is now well and truly over but we are already in full planning mode for 2020! We are looking for speakers to present at the conference in Antwerp next June (23-25) and you can find the details for what types of papers we are looking for on the Conference 2020 page.  We need your ideas by 18th September, so get inspired over the summer and send us your submission.  We are very much looking forward to some outstanding papers, as the bar was set very high this year!  For more information, contact Caroline Snowdon - [email protected] or Bernadette Rogers - [email protected]